Global manufacturing excellence will be a game changer for CMOs that can achieve it.

Providing the right information upfront may ease new requirements to assess solvent levels.

CMO business models are out of touch with current pharma industry realities. It's time for new thinking.

Global manufacturing excellence will be a game changer for CMOs that can achieve it.

CMO business models are out of touch with current pharma industry realities. It's time for new thinking.

CMOs have positive outlook for 2008 but are wary of competitive pressures.

The recent heparin contamination event calls for a new approach to manage a lengthening pharmaceutical supply chain.

Another Asian services provider demonstrates the global nature of pharmaceutical outsourcing.

CMOs have positive outlook for 2008 but are wary of competitive pressures.